Evidence map›Paper›PMID 42146519›Full record

ArticlebioRxiv : the preprint server for biology2026

Cargo-Adaptor Cooperation Programs Retromer Coat Architecture.

Marta Pardo-Piñón, Raffaele Coray, Pengwei Zhang, Changin Oh, Adriana L Rojas, Daniel DiMaio, Daniel Castaño-Díez, Aitor Hierro

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta Pardo-PiñónInstituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain.
Raffaele CorayInstituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain.
Pengwei ZhangDepartment of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Changin OhDepartment of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
Adriana L RojasBasque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain.
Daniel DiMaioDepartment of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-2060-5977
Daniel Castaño-DíezInstituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain.ORCID 0000-0002-0197-163X
Aitor HierroInstituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain.ORCID 0000-0002-7721-1581

Funding

Mechanisms of human papillomavirus entryR35CA242462 · NCI · YALE UNIVERSITY · PI Daniel C. Dimaio · 2020 to 2026
$6.9M
NCI NIH HHS R35 CA242462
6 · The paper itself

Abstract

Retromer drives endosomal cargo retrieval in combination with sorting nexin (SNX) adaptors, but how adaptor-cargo combinations specify coat architecture remains unclear. We identify sorting nexin 12 (SNX12) as the retromer adaptor required for human papillomavirus 16 (HPV16) infection and show that the viral L2 capsid protein tail directly engages SNX12-retromer complexes to trigger membrane tubulation. The crystal structure reveals a conserved cargo-recognition mode, whereas cryo-electron tomography of reconstituted assemblies shows retromer arches organized into two lattice configurations stabilized by membrane-proximal interfaces. These lattices assemble as multi-start helices and accommodate curvature through hinge-like motions between arches. These findings establish cargo and adaptor identity as co-determinants of retromer coat architecture, revealing retromer as a programmable system capable of generating route-specific transport carriers.

Identifiers

PMID42146519
PMCPMC13174498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.